In vitro effect of biological and conventional disease-modifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls

Código QR

In vitro effect of biological and conventional disease-modifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls

Guardado en:

Detalles Bibliográficos
Autores principales:	Helene Broch Tenstad, Pernille Just Vinholt, Christian Nielsen, Hanne Lindegaard, Søren Andreas Just
Formato:	article
Lenguaje:	EN
Publicado:	AVES Yayincilik 2021
Materias:	Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/b20e9e7443864b1fa7afc47c62c455d8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

In vitro evaluation of disease-modifying antirheumatic drugs against rheumatoid arthritis associated pathogens of the oral microflora
por: Stefan Winkler, et al.
Publicado: (2021)

Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
por: Gia Deyab, et al.
Publicado: (2021)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
por: Anne Mirjam Kerola, et al.
Publicado: (2021)

Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis – a systematic review
por: Kingsley GH, et al.
Publicado: (2015)

Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms
por: Ivan Padjen, et al.
Publicado: (2020)

Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70
por: Orme ME, et al.
Publicado: (2012)

Risk of lymphoma and solid cancer among patients with rheumatoid arthritis in a primary care setting.
por: Christen Lykkegaard Andersen, et al.
Publicado: (2014)

Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitis
por: Se Hee Kim, et al.
Publicado: (2021)

Biologic monotherapy in the treatment of rheumatoid arthritis
por: Detert J, et al.
Publicado: (2015)

Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
por: Thao H P Nguyen, et al.
Publicado: (2021)

TNF, SOLUBLE RECEPTORS AND AUTOANTIBODIES TO TNF OF PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTHY DONORS
por: E. A. Golikova, et al.
Publicado: (2012)

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
por: Findeisen KE, et al.
Publicado: (2021)

Single-Cell Transcriptome Profiles Reveal Fibrocytes as Potential Targets of Cell Therapies for Abdominal Aortic Aneurysm
por: Bolun Li, et al.
Publicado: (2021)

Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs
por: Manil Kukar, et al.
Publicado: (2009)

Rheumatoid arthritis hand lesions assessed with outcome measures in rheumatoid arthritis clinical trials-rheumatoid arthritis magnetic resonance imaging score – proposing an extended rheumatoid arthritis magnetic resonance imaging score
por: M. del Carmen Larios-Forte, et al.
Publicado: (2021)

Assessment of depression, anxiety, stress, and quality of life in rheumatoid arthritis patients and comparison with healthy individuals
por: Aslam Khan, et al.
Publicado: (2021)

Baricitinib for the treatment of rheumatoid arthritis
por: Ivan Urits, et al.
Publicado: (2020)

Management of Rheumatoid Arthritis: An Overview
por: Andrei-Flavius Radu, et al.
Publicado: (2021)

The prevalence of rheumatoid arthritis in Spain
por: Lucía Silva-Fernández, et al.
Publicado: (2020)

Rheumatoid arthritis: Disease or syndrome?
por: Jessica A Stanich, et al.
Publicado: (2009)

Infliximab in the treatment of rheumatoid arthritis
por: A Perdriger
Publicado: (2009)

Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
por: Peter BB Jones, et al.
Publicado: (2010)

Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies
por: Fischer PA, et al.
Publicado: (2018)

Phenotypic and functional characterization of synovial fluid-derived fibroblast-like synoviocytes in rheumatoid arthritis
por: Ditte Køster, et al.
Publicado: (2021)

RHEUMATOID ARTHRITIS: LABORATORY MODELS OF THE DISEASE
por: I. A. Orlovskaya, et al.
Publicado: (2015)

Genetics of rheumatoid arthritis: GWAS and beyond
por: McAllister KM, et al.
Publicado: (2011)

Review of tocilizumab in the treatment of rheumatoid arthritis
por: Yasuaki Okuda
Publicado: (2008)

The onset of rheumatoid arthritis following trauma
por: Brawer AE, et al.
Publicado: (2016)

Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
por: Ulusoy H, et al.
Publicado: (2020)

Safety of biologics in rheumatoid arthritis: data from randomized controlled trials and registries
por: Codreanu C, et al.
Publicado: (2015)

Temporomandibular joint problems in patients with rheumatoid arthritis
por: Teresa Sadura-Sieklucka, et al.
Publicado: (2021)

Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
por: Mysler E, et al.
Publicado: (2021)

TELOMERE SHORTENING IN MONOCYTES OF THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: V. I. Borisov, et al.
Publicado: (2014)

CLINICAL AND IMMUNOLOGICAL PARAMETERS IN EARLY RHEUMATOID ARTHRITIS
por: V. V. Sokolova, et al.
Publicado: (2014)

PSYCHOPHYSIOLOGICAL AND IMMUNE STATUS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS
por: T. Y. Abramova, et al.
Publicado: (2014)

Update on the use of rituximab for intractable rheumatoid arthritis
por: R John Looney
Publicado: (2009)

Rheumatoid Arthritis Onset from Shoulder Monoarthritis
por: Ishida K, et al.
Publicado: (2021)

Rituximab therapy in Greek patients with rheumatoid arthritis
por: Haralampos M Moutsopoulos, et al.
Publicado: (2008)

Frequency of sleep disorders in patients with rheumatoid arthritis
por: Mustafa M, et al.
Publicado: (2019)

Certolizumab in the long-term treatment of rheumatoid arthritis
por: Scott DL, et al.
Publicado: (2011)